C
MIRM icon

Covestor’s Mirum Pharmaceuticals MIRM Stock Holding History

Covestor’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$59K Sell
641
-639
-50% -$60.1K 0.04% 602
2025
Q4 		$101K Buy
1,280
+1,239
+3,022% +$88.9K 0.05% 574
2025
Q3 		$3K Hold
41
– – ﹤0.01% 1888
2025
Q2 		$2K Sell
41
-9
-18% -$401 ﹤0.01% 1859
2025
Q1 		$2K Sell
50
-21
-30% -$990 ﹤0.01% 1861
2024
Q4 		$3K Buy
71
+56
+373% +$2.33K ﹤0.01% 1812
2024
Q3 		$1K Sell
15
-8
-35% -$319 ﹤0.01% 2035
2024
Q2 		$1K Buy
23
+20
+667% +$524 ﹤0.01% 2052
2024
Q1 		$0 Hold
3
– – ﹤0.01% 2539
2023
Q4 		$0 Sell
3
-1
-25% -$30 ﹤0.01% 2480
2023
Q3 		$0 Hold
4
– – ﹤0.01% 2461
2023
Q2 		$0 Buy
+4
New +$106 ﹤0.01% 2443
2022
Q4 		– Sell
-1
Closed – – 2380
2022
Q3 		$0 Buy
+1
New +$24 ﹤0.01% 2352

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Covestor's MIRM Position: Q1 2026 in Review

Covestor reduced its Mirum Pharmaceuticals (MIRM) stake by 50% in Q1 2026, selling an estimated $60.1K and leaving 641 shares worth $59K. The position accounts for 0.04% of the portfolio, ranked #602.

Covestor first reported a position in MIRM in Q3 2022 and has held it in 13 quarters since. The position peaked at $101K in Q4 2025. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Covestor held 641 shares of Mirum Pharmaceuticals worth $59K as of Q1 2026.
  • Covestor sold 639 Mirum Pharmaceuticals shares in Q1 2026, an estimated $60.1K.
  • Mirum Pharmaceuticals made up 0.04% of Covestor's portfolio in Q1 2026, its #602 holding.
  • Covestor first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 13 quarters since.
  • Covestor's Mirum Pharmaceuticals position peaked at $101K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.